LifeMD, Inc. (LFMDP)
USD 23.41
(0.46%)
USD 23.41
(0.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.75 Million USD | -25.47% |
| 2022 | 3.7 Million USD | 129.08% |
| 2021 | 1.61 Million USD | 27.87% |
| 2020 | 1.26 Million USD | 33.07% |
| 2019 | 950.05 Thousand USD | -7.1% |
| 2018 | 1.02 Million USD | 44.61% |
| 2017 | 707.16 Thousand USD | 341.23% |
| 2016 | 160.27 Thousand USD | 162.52% |
| 2015 | 61.05 Thousand USD | 48.88% |
| 2014 | 41 Thousand USD | -52.42% |
| 2013 | 86.19 Thousand USD | 36.0% |
| 2012 | 63.37 Thousand USD | 7.79% |
| 2011 | 58.8 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.06 Million USD | -13.18% |
| 2024 Q1 | 2.37 Million USD | -14.0% |
| 2023 Q1 | 3.38 Million USD | -8.66% |
| 2023 Q4 | 2.75 Million USD | -27.19% |
| 2023 Q2 | 3.69 Million USD | 9.33% |
| 2023 Q3 | 3.79 Million USD | 2.5% |
| 2023 FY | 2.75 Million USD | -25.47% |
| 2022 Q3 | 3.67 Million USD | 23.97% |
| 2022 Q2 | 2.96 Million USD | 139.13% |
| 2022 Q1 | 1.24 Million USD | -23.29% |
| 2022 FY | 3.7 Million USD | 129.08% |
| 2022 Q4 | 3.7 Million USD | 0.74% |
| 2021 FY | 1.61 Million USD | 27.87% |
| 2021 Q3 | 1.58 Million USD | -1.67% |
| 2021 Q4 | 1.61 Million USD | 1.86% |
| 2021 Q2 | 1.61 Million USD | -3.6% |
| 2021 Q1 | 1.67 Million USD | 32.44% |
| 2020 Q3 | 1.85 Million USD | 129.78% |
| 2020 FY | 1.26 Million USD | 33.07% |
| 2020 Q1 | 554.28 Thousand USD | -41.66% |
| 2020 Q2 | 808.84 Thousand USD | 45.93% |
| 2020 Q4 | 1.26 Million USD | -31.98% |
| 2019 Q2 | 703.28 Thousand USD | -19.82% |
| 2019 Q1 | 877.14 Thousand USD | -14.23% |
| 2019 Q4 | 950.05 Thousand USD | 27.09% |
| 2019 FY | 950.05 Thousand USD | -7.1% |
| 2019 Q3 | 747.52 Thousand USD | 6.29% |
| 2018 Q3 | 623.44 Thousand USD | 22.92% |
| 2018 FY | 1.02 Million USD | 44.61% |
| 2018 Q4 | 1.02 Million USD | 64.03% |
| 2018 Q2 | 507.21 Thousand USD | -15.63% |
| 2018 Q1 | 601.17 Thousand USD | -14.99% |
| 2017 Q1 | 136.93 Thousand USD | -14.56% |
| 2017 Q2 | 127.44 Thousand USD | -6.93% |
| 2017 Q3 | 377.8 Thousand USD | 196.43% |
| 2017 Q4 | 707.16 Thousand USD | 87.18% |
| 2017 FY | 707.16 Thousand USD | 341.23% |
| 2016 Q3 | 130.53 Thousand USD | -27.18% |
| 2016 FY | 160.27 Thousand USD | 162.52% |
| 2016 Q1 | 138.49 Thousand USD | 126.85% |
| 2016 Q2 | 179.25 Thousand USD | 29.43% |
| 2016 Q4 | 160.27 Thousand USD | 22.78% |
| 2015 Q2 | 21.47 Thousand USD | -50.58% |
| 2015 Q4 | 61.05 Thousand USD | 54.84% |
| 2015 Q3 | 39.42 Thousand USD | 83.57% |
| 2015 Q1 | 43.46 Thousand USD | 5.98% |
| 2015 FY | 61.05 Thousand USD | 48.88% |
| 2014 Q2 | 83.51 Thousand USD | -5.16% |
| 2014 Q1 | 88.06 Thousand USD | 2.17% |
| 2014 Q4 | 41 Thousand USD | -25.26% |
| 2014 Q3 | 54.86 Thousand USD | -34.31% |
| 2014 FY | 41 Thousand USD | -52.42% |
| 2013 Q2 | 64.04 Thousand USD | -6.87% |
| 2013 Q1 | 68.77 Thousand USD | 8.52% |
| 2013 FY | 86.19 Thousand USD | 36.0% |
| 2013 Q4 | 86.19 Thousand USD | -28.2% |
| 2013 Q3 | 120.04 Thousand USD | 87.43% |
| 2012 Q3 | 36.94 Thousand USD | 0.0% |
| 2012 FY | 63.37 Thousand USD | 7.79% |
| 2012 Q4 | 63.37 Thousand USD | 71.55% |
| 2011 FY | 58.8 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 7.65 Million USD | 63.942% |
| China Jo-Jo Drugstores, Inc. | 17.16 Million USD | 83.919% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 10.86 Million USD | 74.603% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 10.86 Million USD | 74.603% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| LifeMD, Inc. | 2.75 Million USD | 0.0% |
| TRxADE HEALTH, Inc. | 968.00 USD | -285016.942% |
| PetMed Express, Inc. | 28.55 Million USD | 90.335% |
| Walgreens Boots Alliance, Inc. | 8.32 Billion USD | 99.967% |